VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 362 filers reported holding VANECK VECTORS ETF TR in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,504,000 | -51.3% | 85,509 | -55.6% | 0.24% | -39.4% |
| Q3 2019 | $5,141,000 | -51.8% | 192,465 | -59.5% | 0.40% | -33.6% |
| Q1 2019 | $10,663,000 | -25.3% | 475,595 | -38.3% | 0.60% | -30.9% |
| Q3 2018 | $14,267,000 | +3644.6% | 770,355 | +4405.8% | 0.87% | +5041.2% |
| Q2 2018 | $381,000 | -74.3% | 17,097 | -74.7% | 0.02% | -78.8% |
| Q1 2018 | $1,484,000 | -26.5% | 67,507 | -22.3% | 0.08% | -25.2% |
| Q4 2017 | $2,020,000 | -96.8% | 86,917 | -96.8% | 0.11% | -96.6% |
| Q3 2017 | $63,277,000 | +184.0% | 2,755,966 | +173.1% | 3.13% | +1.5% |
| Q2 2017 | $22,282,000 | -7.8% | 1,009,143 | -4.8% | 3.09% | +23.8% |
| Q1 2017 | $24,176,000 | +85.4% | 1,059,873 | +70.0% | 2.50% | +79.8% |
| Q4 2016 | $13,040,000 | +497.3% | 623,312 | +654.7% | 1.39% | +270.1% |
| Q3 2016 | $2,183,000 | – | 82,593 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |